@decipherbio.com
Veracyte offers Decipher genomic testing for prostate and bladder cancers.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Icon
JPEG
About
Description
Decipher is a brand dedicated to genomic profiling for prostate and bladder cancers, enabling a deeper understanding of the underlying biology of the patient's disease. With a focus on clarity and confidence in treatment planning, Decipher offers genomic testing for urological cancers. Decipher Prostate, a genomic classifier, helps physicians stratify patients by the risk of prostate cancer progression.
By using Decipher, doctors can identify which patients may benefit from less intensive treatment approaches or require additional and more intensive treatment. This empowers patients in their prostate cancer journey by providing more accurate risk stratification. In addition to prostate cancer, Decipher also offers Decipher Bladder for patients with T1 or muscle-invasive bladder cancer.
Decipher Bladder classifies bladder cancer tumors by molecular subtype, assisting physicians in determining which patients are at the highest risk of upstaging at radical cystectomy and which would benefit most from neoadjuvant chemotherapy. Validated in over 75 studies, encompassing more than 60,000 patients, Decipher provides extensive validation for metastasis, prostate cancer-specific mortality, and overall survival. Contact Decipher for more information, resources, or to schedule a genomic testing appointment
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories